Cart
sales@molnova.com
Neuromedin B
CAS No. 87096-84-2
Neuromedin B( —— )
Catalog No. M30141 CAS No. 87096-84-2
Neuromedin B (NMB) is one of the bombesin (BN)-related peptides in mammals. It was originally purified from pig spinal cords, and it has been shown to be present in central nervous system as well as in gastrointestinal tract.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 267 | In Stock |
|
| 10MG | 482 | In Stock |
|
| 25MG | 781 | In Stock |
|
| 50MG | 1062 | In Stock |
|
| 100MG | 1431 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
Biological Information
-
Product NameNeuromedin B
-
NoteResearch use only, not for human use.
-
Brief DescriptionNeuromedin B (NMB) is one of the bombesin (BN)-related peptides in mammals. It was originally purified from pig spinal cords, and it has been shown to be present in central nervous system as well as in gastrointestinal tract.
-
DescriptionNeuromedin B (NMB) is one of the bombesin (BN)-related peptides in mammals. It was originally purified from pig spinal cords, and it has been shown to be present in central nervous system as well as in gastrointestinal tract.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
Recptor——
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number87096-84-2
-
Formula Weight1132.29
-
Molecular FormulaC52H73N15O12S
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?H2O : 12.5 mg/mL (11.04 mM)
-
SMILES——
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
Methyl protodioscin
Methyl protodioscin potentially increase HDL cholesterol while reducing LDL cholesterol and triglycerides. Methyl protodioscin has antitumor property.
-
Chebulic acid
Chebulic acid, a phenolcarboxylic acid compound isolated from Terminalia chebula, has potent anti-oxidant activity, which breaks the cross-links of proteins induced by advanced glycation end-products (AGEs) and inhibits the formation of AGEs.
-
RNase L-IN-2
RNase L-IN-2 is an activator of RNase L with EC50 of 22 uM;?shows broad-spectrum antiviral activity against diverse types of RNA viruses, including the human pathogen human parainfluenza virus type 3, with no cytotoxic at the effective concentrations.
